Chronic comorbidity of internal organs as a risk factor of complications and fatal outcome of community-acquired pneumonia.

Authors

  • Y. M. Mostovoy
  • A. V. Demchuk
  • T. V. Konstantynovych
  • K. D. Chichirelo-Konstantynovych

DOI:

https://doi.org/10.26641/2307-0404.2018.1(part1).127248

Keywords:

community-acquired pneumonia, chronic diseases of internal organs

Abstract

With the purpose to estimate influence of comorbidity at the risk of complications and death due to community-acquired pneumonia (CAP) the retrospective analysis of 1587 case histories of inpatients with CAP (mean age – 48.5±18.4, males – 815 (51.4%), women – 772 (48,6%)) was performed. Comorbidity was observed in 1114 (70.2%). More frequently complications of CAP were developed in patients with chronic diseases than without them (p=0.013). Increased risk of pleural effusion was associated with chronic diseases of digestive system (OR=1.85 (95%CI 1.30-2.26)) and diabetes mellitus (OR=2.35 (95%CI 1.40-3.96)). Risk of sepsis development is higher in patients with nervous system diseases (OR=3.62 (95%CI 1.37-9.56) and drug or alcohol addiction (OR=19.08 (95%CI 7.30-49.82). Risk of pulmonary edema rose in patients with drug or alcohol addiction (OR=24.16; 95%CI 8.07-72.34), malignancy (OR=8.97; 95%CI 1.94-41.49), diabetes mellitus (OR=4.04; 95%CI 1.48-11.01), diseases of nervous (OR=4.04; 95%CI 1.17-13.94), urinary (OR=3.39; 95%CI 1.33-8.64) and cardiovascular (OR=2.29, 95%CI 0.98-5.34) systems. Higher risk of death in patients with CAP was associated with the presence of cardiovascular diseases (OR=2.17; 95%CI 1.11-4.25), diabetes mellitus (OR=2.95; 95%CI 1.20-7.21), drug or alcohol addiction (OR=38.40; 95%CI 15.05-97.98).

 

Author Biographies

Y. M. Mostovoy

National Pirogov Memorial Medical University, Vinnytsya
Department of Propaedeutics internal medicine
Pirogova str, 56, Vinnytsya, 21018, Ukraine

A. V. Demchuk

National Pirogov Memorial Medical University, Vinnytsya
Department of Propaedeutics internal medicine
Pirogova str, 56, Vinnytsya, 21018, Ukraine

T. V. Konstantynovych

National Pirogov Memorial Medical University, Vinnytsya
Department of Propaedeutics internal medicine
Pirogova str, 56, Vinnytsya, 21018, Ukraine

K. D. Chichirelo-Konstantynovych

National Pirogov Memorial Medical University, Vinnytsya
Department of Propaedeutics internal medicine
Pirogova str, 56, Vinnytsya, 21018, Ukraine

References

Ivanovskiy VB,PaukerMN,NeyshtandtAS.[Sta­ges and quality of medical diagnosis of long-term pneumonia in a tuberculosis hospital]. Klinicheskaya Medicina 2011;1:31-34. Russian.

Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Intern Med. 2013;52:317-24.

Sellares J, Lopez-Giraldo A. Lucena C, et al. In­fluence of previous use of inhaled corticoids on the de­velopment of pleural effusion in community-acquired pneumonia. Am J Respir Crit Care Med. 2013;187(11):1241-8.

Kolditz M, Ewig S, Hoffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 2013;41:974984.

Ruhnke GW, Coca-Perraillon M, Kitch BT, et al. Marked improvement in 30-day mortality among elderly inpatients and outpatients with community-acquired pneu­monia. Am J Med. 2011;124:171-8.

Almirall J, Bolibar I, Serra-Prat M, et al. New evi­dence of risk factors for community-acquired pneu­monia: a population-based study. Eur Respir J. 2008;31:1274-84.

Martin-Loeches I, Valles X, Menendez R, et al. Pre­dicting treatment failure in patients with community-acquired pneumonia: a case-control study. Respir Res 2014;15(1):75.

Sibila O, Mortensen EM, Anzueto A, et al. Prior car­diovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J 2014;43:36-42.

Sicras-Mainar A, Ibanez-Nolla J, Cifuentes I, et al. Retrospective epidemiological study for the charac­terization of community-acquired pneumonia and pneu­mococcal pneumonia in adults in a well-defined area of Ba­dalona (Barcelona, Spain). BMC Infect Dis 2012;12:283. Available from: http://www.biomedcentral.com/1471-2334/­12/283

Dusemuna F, Chronis J, Baty F, et al. The out­come of community-acquired pneumonia in patients with chronic lung disease. Swiss Med Wkly 2014;144:w14013. Available from: www.smw.ch

Torres A, Blasi F, Dartois N, et al. Which in­dividuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax 2015;70:984-9.

How to Cite

1.
Mostovoy YM, Demchuk AV, Konstantynovych TV, Chichirelo-Konstantynovych KD. Chronic comorbidity of internal organs as a risk factor of complications and fatal outcome of community-acquired pneumonia. Med. perspekt. [Internet]. 2018Apr.24 [cited 2024Jul.13];23(1(part1):112-7. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/127248

Issue

Section

CLINICAL MEDICINE